Evidence map›Paper›PMID 38623037›Full record

ArticleACS biomaterials science & engineering2024

Supramolecular Peptide Self-Assemblies Facilitate Oral Immunization.

Elizabeth J Curvino, Mia E Woodruff, Emily F Roe, Helena Freire Haddad, Pablo Cordero Alvarado, Joel H Collier

Open access · greenAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elizabeth J CurvinoDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Mia E WoodruffDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Emily F RoeDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Helena Freire HaddadDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Pablo Cordero AlvaradoDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.ORCID 0009-0003-4326-1067
Joel H CollierDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.ORCID 0000-0003-3536-4827
Duke University · US

Funding

Modular Self-Assembled Coatings for BiomaterialsR01EB009701 · NIBIB · UNIVERSITY OF CHICAGO · PI COLLIER, JOEL H · 2009 to 2021
$4.3M
Supramolecular biomaterials for tuning the inflammatory properties of the complement systemR01AI172151 · NIAID · DUKE UNIVERSITY · PI COLLIER, JOEL H · 2022 to 2025
$2.8M
NIAID NIH HHS R01 AI172151NIBIB NIH HHS R01 EB009701
6 · The paper itself

Abstract

Oral immunization is a promising strategy for preventing and treating gastrointestinal (GI) infections and diseases, as it allows for direct access to the disease site. To elicit immune responses within the GI tract, however, there are many obstacles that oral vaccines must surmount, including proteolytic degradation and thick mucus barriers. Here, we employed a modular self-assembling peptide nanofiber platform to facilitate oral immunization against both peptide and small molecule epitopes. Synthesizing nanofibers with d-amino acids rendered them resistant to proteases in vitro, whereas l-amino acid nanofibers were rapidly degraded. Additionally, the inclusion of peptide sequences rich in proline, alanine, and serine (PAS), increased nanofiber muco-penetration, and accelerated nanofiber transport through the GI tract. Oral immunization with PASylated nanofibers and mucosal adjuvant generated local and systemic immune responses to a peptide epitope but only for l-amino acid nanofibers. Further, we were able to apply this design to also enable oral immunization against a small molecule epitope and illustrated the therapeutic and prophylactic effectiveness of these immunizations in mouse models of colitis. These findings demonstrate that supramolecular peptide self-assemblies have promise as oral vaccines and immunotherapies.

Indexed as

ImmunizationNanofibersPeptidesAdministration, OralAnimalsColitisEpitopesFemaleMiceMice, Inbred C57BLEpitopesPeptidesmucosaloral deliveryself-assembling peptidessupramolecularvaccine

Identifiers

PMID38623037
PMCPMC11382288
OpenAlexW4394853783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.